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Background: Accurate neuroendocrine neoplasia (NEN) staging is vital for determining prognosis and therapeutic
strategy. The great majority of NENs express chromogranin A (CgA) which can be detected at a protein or
transcript level. The current standards for lymph node metastasis detection are histological examination after
Hematoxylin and Eosin (H&E) and CgA immunohistochemical (IHC) staining. We hypothesized that detection of CgA
mRNA transcripts would be a more sensitive method of detecting these metastases.
Findings: We compared these traditional methods with PCR for CgA mRNA extracted from formalin fixed paraffin
embedded slides of lymph nodes (n= 196) from small intestinal NENs, other gastrointestinal cancers and benign
gastrointestinal disease. CgA PCR detected significantly more NEN lymph nodes (75%) than H&E (53%) or CgA IHC
(57%) (p= 0.02). PCR detected CgA mRNA in 50% (14 of the 28) of SI-NEN lymph nodes previously considered
negative. The false positive rate for detection of CgA mRNA was 19% in non-neuroendocrine cancers, and appeared
to be due to occult neuroendocrine differentiation or contamination by normal epithelium during histological
processing.
Conclusions: Molecular pathological analysis demonstrates the limitations of observer-dependent histopathology.
CgA PCR analysis detected the presence of CgA transcripts in lymph nodes without histological evidence of tumor
metastasis. Molecular node positivity (stage molN1) of SI-NEN lymph nodes could confer greater staging accuracy
and facilitate early and accurate therapeutic intervention. This technique warrants investigation using clinically
annotated tumor samples with follow-up data.
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Research hypothesis
The prognosis of solid malignancies is inextricably linked
to the extent of invasion and spread from the site of the
primary tumor, known as the “tumor stage”. Tumors that
exhibit metastases to regional lymph nodes have a worse
prognosis than tumors that remain localized within the* Correspondence: mark.kidd@yale.edu; imodlin@optonline.net
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reproduction in any medium, provided the orprimary organ, since cure is more likely after surgery for
localized disease. Tumor lymph node metastases are usu-
ally identified during examination of resected lymph nodes
on paraffin embedded histological slides stained with
Hematoxylin and Eosin (H&E), and the detection of tumor
cells in ambiguous cases is aided by immunohistochemical
(IHC) staining for the tumor marker protein Chromogra-
nin A (CgA).
An alternative objective technique for assessment of
lymph node metastasis is Quantitative Real Time PCR.
This technique has been previously used to detectral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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expression of tumor marker RNA transcripts in lymph
nodes resected in the setting of non-neuroendocrine can-
cers [1-9]. We hypothesized that a PCR-based approach
for CgA detection would be more sensitive than either
H&E or CgA IHC for detecting lymph node metastases.
Methods
Study tissue was stored and collated according to the
requirements of the Institutional Review Board at Yale
New Haven Hospital. All resections for SI-NENs between
the years 2000 and 2010 were included in the study. Con-
trol tissue was obtained from lymph nodes extracted at the
time of resection of non-neuroendocrine malignancy or
non-malignant conditions in organs which exhibit similar
mesenteric lymph node drainage as SI-NENs. Three con-
tiguous histological slides were randomly assigned to H&E
staining, CgA IHC, or RNA extraction for CgA PCR
(PCR).
H&E and IHC staining of the paraffin-embedded
slides were conducted using standard clinical patho-
logical methodology. IHC staining used the Chromogranin
A primary antibody, MS-382 (NeoMarkers, Thermo Scien-
tific, Fremont, CA) applied at a 1:1000 concentration.
Slides assigned to CgA PCR were processed by scraping
tumor tissue from unstained paraffin embedded slides and
RNA extracted using QuickExtractTM FFPE RNA Extrac-
tion Kit (Epicentre Biotechnologies, Madison, WI). Total
RNA from each sample was subjected to reverse tran-
scription with the High Capacity cDNA Archive Kit (ABI,
Foster City, CA). The method included 2 μg of total RNAFigure 1 Examples of NEN metastasis and the proportion of regional
Chromogranin A immunohistochemical positivity or Chromogranin A
H&E stain, 20X (1a) and Chromogranin A IHC stain, 20X (1b) on contiguous
between the proportion of positive tumors (p= 0.020), and Dunn’s post ho
CgA PCR (1c).in 50μL of water mixed with 50μL of 2X RT mix contain-
ing Reverse Transcription Buffer, dNTPs, random primers
and Multiscribe Reverse Transcriptase. RT reaction was
carried out in a thermal cycler for 10 minutes at 25 °C
followed by 120 minutes at 37 °C. Quantitative Real-time
PCR (qRT-PCR) analysis was then performed in duplicate
[10] using the ABI 7900 Sequence Detection System
(Applied Biosystems, Foster City, CA). We mixed cDNA
in 7.2μL of water with 0.8μL of 20X Assays-on-Demand
primer and probe mix and 8μL of 2X TaqMan Universal
Master mix in a 384-well optical reaction plate. The fol-
lowing PCR conditions were used: 50 °C for 2 minutes,
then 95 °C for 10 minutes, followed by 40 cycles at 95 °C/
15 seconds and 60 °C/60 seconds. A standard curve was
generated for each gene using cDNA obtained by pooling
equal amounts from each sample. Detection of CgA by
qRT-PCR was conducted using 3 separate and non-
overlapping primers (Applied Biosystems, Foster, CA) to
achieve representative coverage of the 8 exon CgA gene
(CHGA Hs00900369_s1, Hs00900371_s1, Hs00900373).
The expression level of target genes was normalized to in-
ternal 18S; the presence of other housekeeping genes
ALG9 and GAPDH was examined but was not utilized in
calculations because these two genes were not consistently
detectable in the tumor samples. The coefficient of vari-
ation for cycle time was similar between 18S and the three
Chromogranin A target genes (18S 10.37%, CgA_69
14.46%, CgA_71 13.07%, CgA_73 13.93%). Detection of
CgA by qRT-PCR was conducted using 3 separate and
non-overlapping primers (Applied Biosystems, Foster, CA)
to achieve representative coverage of the 8 exon CgA genelymph nodes that exhibit histological tumor involvement,
transcript expression. A NEN lymph node metastasis stained with
slices of an involved lymph node. There was a significant difference
c tests showed a significant difference between H&E staining or








No Distant Metastases 6 / 9 8 / 9 22%*
Distant Metastases 11 / 12 12 / 12 8%
Total 17 / 21 20 / 21 14%
*Upstaging by TNM criteria.
The 21 SI-NENs included 3 patients with localized disease, 6 with nodal
metastasis according to H&E assessment, and 12 with distant metastases (one
was lymph node negative). PCR upstaged 2 of the 3 node negative patients to
node positive, and the patient with node negative but metastatic disease was
also node positive on PCR. Thus 3 of 21 (14%) patients were upstaged to node
positive disease, with 2 patients upstaged in TNM staging.
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Lymph nodes were considered positive for the presence of
CgA by PCR if two criteria were met: one (or more) of the
three primers detected expression of that primer, and ex-
pression was 5-fold increased relative to lymph nodes from
benign gastrointestinal disease. Three pathologists inde-
pendently examined the 388 stained slides presented in a
random order and determined whether the lymph node
was positive for NEN metastasis. Following this rating step,
one pathologist (BK) examined each slide to quantify the
extent of tumor involvement and the presence of non-
malignant non-lymphoid normal tissue.
A power analysis (α 0.05, power of 0.80, Glass’s delta
0.56, sd 0.49) was conducted prior to sample collectionFigure 2 Chromogranin A transcript expression level of and degree o
expression level of 3 different CgA primers, namely CHGA Hs00900369_s1 (
shown. The expression level of CgA differs significantly in all three primers
shows significantly higher expression in the ‘total replacement’ group than
hoc tests show a significant difference between ‘Nil’ and ‘partial replacemebased on a pilot study of 22 SI-NEN lymph nodes which
determined a sample size of 52 per group.
Results
The sample included 61 lymph nodes from 21 patients
with NENs (n=20 SI-NENs, n=1 gastric NEN), 115
lymph nodes from 19 patients with non-neuroendocrine
cancers, and 19 lymph nodes from 11 patients with non-
malignant disease. Concordance between the three pathol-
ogists regarding neuroendocrine tumor involvement was
96.4% on H&E staining and 97.4% on CgA IHC. In NEN
regional lymph nodes, CgA transcripts (77%, 47/61) were
detected significantly more frequently than tumor cells on
H&E staining (Figure 1a; 54%, 33/61) or CgA protein (Fig-
ure 1b; 56%, 34/61) on IHC staining (see Figure 1c;
p=0.02, post-hoc testing H&E vs PCR significant). Two
lymph nodes that were positive on H&E staining were
negative for CgA transcript, making a total of 49/61
(80.3%) positive nodes on H&E and PCR combined, com-
pared to 33/61 (54.1%) on H&E alone (p=0.003). Consid-
ering the 21 NEN cases on a patient-by-patient basis, 9
had at least one H&E negative node upstaged to positive
by PCR. Of the three patients with localized disease
(TxN0M0), two were upstaged to lymph node positive dis-
ease (TxN1M0) by PCR analysis (Table 1), and one patient
with distant metastases was upstaged from node-negative
to node-positive. Of the 21 NEN cases, 19 patients remain
alive, thus preventing a prognostic analysis of survival.f lymph node involvement by tumor. The mean (and SEM)
2a), CHGA Hs00900371_s1 (2b), and CHGA Hs00900373_s1 (2c) is
(p< .0001, p= .0004 and p< .0001 respectively). Post-hoc testing
in the ‘nil’ or ‘minimal tumor’ groups for all primers. In addition, post
nt’ in the primer shown in 2c.
Figure 3 Suspicious “tumor” cell clusters in lymph nodes that are negative for tumor metastasis on examination after H&E staining
but positive for CgA RNA after PCR of lymph node tissue. The arrows point to suspicious minute cell clusters in case (3a) and (3b), shown
under lower and higher magnification.
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transcripts and lymph node involvement was investigated.
The level of transcript expression was correlated with the
degree of tumor involvement of lymph nodes across all
three CgA primers (Figure 2), with higher levels of CgA ex-
pression seen in lymph nodes with majority or complete
replacement by NEN.
Of the 28 lymph nodes without histological tumor
involvement, 14 had detectable CgA by PCR. TheseFigure 4 Examples of epithelial contamination of lymph nodes extrac
during sample processing. These figures show small fragments of epithe
contiguous slides after Immunostaining for CgA (4b and 4d) in lymph nod
epithelium contain normal neuroendocrine cells (indicated by arrows) and
magnification and the lower row at 40x magnification.cases were carefully retrospectively reviewed (following un-
blinding) for possible NEN involvement. Many cases had
rare/subtle suspicious cells seen on high magnification
which were likely to be below the threshold for H&E diag-
nosis of metastasis. (Examples are shown in Figure 3).
The rate of CgA mRNA positivity in the lymph nodes
resected with non-neuroendocrine cancers was 29 of 115
(25%). Of the 29 lymph nodes with detectable CgA tran-
script from the non-neuroendocrine malignancies, 7 nodested with non-neuroendocrine malignancies, presumably caused
lium after H&E staining (4a and 4c) and matching epithelium in
e samples that exhibit PCR positivity. These tiny pieces of normal
therefore CgA transcripts are detectable. The top row is shown at 20x
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atic, rectal, small intestinal) that had positive CgA IHC or
histological evidence of neuroendocrine differentiation,
and so should be regarded as exhibiting neuroendocrine
differentiation and the CgA PCR result are interpreted as a
true positive in terms of tumor phenotype. The non-
neuroendocrine cancers were then examined on a case-by-
case basis to determine whether the distribution of the
remaining 22 (19.1%) lymph nodes with detectable CgA
transcripts was related to characteristics of the resected
tumor (Additional file 1: Table S1A). There was no rela-
tionship between clinical variables and the presence of
CgA mRNA; transcript detection did not relate to age, gen-
der, stage, grade, or primary site. Rather, the low level of
lymph node positivity detected across the majority of non-
neuroendocrine cancers raised the possibility that a more
general and non-prognostic phenomenon might account
for this finding. Therefore, the presence and nature of ex-
traneous tissue other than lymph node or metastasis was
quantified for all 195 lymph nodes by examination of the
H&E slide. Nearly one half of the slides contained add-
itional tissue adjacent to (or sometimes within) the lymph
node (Additional file 1: Table S1B), but there was no rela-
tionship between the type of contamination on the slide
and the likelihood of CgA transcript detection. The most
common contaminant was microscopic fragments of epi-
thelium from small bowel. These strips of epithelium con-
tained cells with IHC positive staining for CgA, suggesting
that CgA transcript detection could occur in absence of
NEN metastasis by the detection of normal neuroendo-
crine cells exogenously introduced by mucosal or epithelial
contamination during histological processing (Figure 4).
This type of systematic error in processing was also sug-
gested by the similar frequency of transcript positivity be-
tween non-neuroendocrine cancer and benign diseases
(19% and 21% respectively). There were also some cases of
macroscopic pancreatic or bowel wall tissue on the slide.
Conclusions
In this study, regional mesenteric lymph nodes from
resected SI-NENs were examined for the histological pres-
ence of metastasized NEN cells, the immunohistochemical
presence of CgA protein, or the presence of CgA mRNA
by PCR. CgA transcripts were detected at a significantly
higher rate than NEN cells by examination after H&E or
CgA IHC staining. Since it is evident that anti neoplastic
therapy is more effective as tumor burden decreases [11],
and the presence of lymph node metastases has been vali-
dated as a key prognostic variable in NENs [12,13] the
identification of lymph node metastasis has significant
implications on the timing of therapy and its efficacy. An
issue awaiting clarification is the significance of CgA tran-
scripts detected in lymph nodes from some non-
neuroendocrine tumors, which could represent eitheroccult neuroendocrine differentiation (24% exhibited histo-
logical or IHC evidence of neuroendocrine differentiation)
or false positive tumor detection. The detection of CgA
mRNA could represent contamination by normal neuroen-
docrine cells contained in the gastrointestinal mucosa, al-
though there was no difference in CgA transcript detection
between slides contaminated with epithelial versus non-
epithelial cells to support this. On the other hand, there
has been considerable discussion about NE cells as the ori-
gin of some GI cancers and this may represent the detec-
tion of alterations in cell lineage in evolution of an
adenocarcinoma [14-16].
We have demonstrated that the PCR detection of CgA
transcripts from paraffin embedded lymph node tissue is a
feasible technique with potential clinical utility. Validation
in a large sample of clinically annotated tumors is therefore
warranted.
Availability of supporting data
Additional file 1 Table S1A and S1B are included are avail-
able at [hyperlink].
Additional file
Additional file 1: Table S1A. The traditional prognostic characteristics
of the non-neuroendocrine cancers and the proportion of lymph nodes
with Chromogranin A transcript detection. The distribution of PCR
positive lymph nodes occurred irrespective of primary site, differentiation,
grade and stage. Table S1B. Proportion of lymph nodes that show
detectable CgA transcripts in the absence of histological evidence of
neuroendocrine tumor according to the presence of extraneous tissue.
There was no relationship between the nature of contamination and the
likelihood of CgA transcript detection, and in particular, the presence of
epithelial cell “contamination” did not increase the detection of CgA
transcripts. Also, 3 of the 6 lymph nodes with adenocarcinoma cells
visible on histological examination also demonstrated CgA IHC positivity,
consistent with detection of neuroendocrine differentiation by CgA PCR.
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